Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 6,244 shares at $27.50 ($172K) on 2024-02-08, disclosed to the SEC on 2024-02-12.
Scheduled sale ($172k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 1,332 | $37K | 21.3% |
| 2 | $27.50 | 1,996 | $55K | 32.0% |
| 3 | $27.50 | 2,916 | $80K | 46.7% |
| Total | $27.50 avg | 6,244 | $172K | 100% |
| Filing → |
| FDMT | SELL | 2026-08-17 | $40K | — | Filing → |
| FDMT | SELL | 2026-07-02 | $92K | — | Filing → |
| FDMT | SELL | 2026-06-25 | $118K | — | Filing → |